Mitsubishi UFJ Asset Management Co. Ltd. Invests $530,000 in Inspire Medical Systems, Inc. $INSP

Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 11,875 shares of the company’s stock, valued at approximately $530,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Alberta Investment Management Corp purchased a new position in Inspire Medical Systems during the 2nd quarter worth $5,483,000. Bank of New York Mellon Corp purchased a new stake in shares of Inspire Medical Systems in the second quarter valued at about $6,630,000. GSA Capital Partners LLP purchased a new stake in shares of Inspire Medical Systems in the second quarter valued at about $820,000. Handelsbanken Fonder AB boosted its stake in shares of Inspire Medical Systems by 44.9% during the second quarter. Handelsbanken Fonder AB now owns 14,200 shares of the company’s stock worth $633,000 after buying an additional 4,400 shares during the period. Finally, Tactive Advisors LLC acquired a new stake in shares of Inspire Medical Systems during the second quarter worth about $287,000. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Stock Up 1.9%

Shares of NYSE:INSP opened at $62.45 on Friday. Inspire Medical Systems, Inc. has a fifty-two week low of $38.91 and a fifty-two week high of $147.03. The firm’s 50-day simple moving average is $51.14 and its 200-day simple moving average is $52.77. The company has a market cap of $1.81 billion, a price-to-earnings ratio of 13.52, a PEG ratio of 4.74 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.38. The firm had revenue of $200.58 million during the quarter, compared to analysts’ expectations of $194.72 million. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The firm’s revenue for the quarter was down 7.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.45 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, research analysts forecast that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Insider Transactions at Inspire Medical Systems

In other Inspire Medical Systems news, insider Jason P. Kelly sold 963 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the transaction, the insider owned 18,985 shares in the company, valued at approximately $1,130,556.75. The trade was a 4.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on INSP. Evercore set a $54.00 price target on Inspire Medical Systems in a research report on Tuesday, August 4th. KeyCorp reaffirmed a “sector weight” rating on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Oppenheimer upgraded Inspire Medical Systems from a “market perform” rating to an “outperform” rating and set a $85.00 target price on the stock in a research note on Tuesday, August 4th. JPMorgan Chase & Co. boosted their target price on Inspire Medical Systems from $54.00 to $60.00 and gave the company a “neutral” rating in a report on Tuesday, August 4th. Finally, Piper Sandler upped their price target on Inspire Medical Systems from $55.00 to $60.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Inspire Medical Systems currently has an average rating of “Hold” and a consensus price target of $66.19.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.